Perrigo’s Ketoconazole Foam, 2% is generic equivalent to Extina Ketoconazole Foam, 2%.
Ketoconazole Foam, 2% is indicated for topical treatment of seborrheic dermatitis in immunocompetent patients 12 years of age and older.
Perrigo chairman and CEO Joseph Papa said this launch reflects their continuing investment in new products.
"It is an example of the excellent partnership we have with Cobrek for developing foam products which is a key product category for our Rx business," Papa said.